LCS12 vs. ENG Subdermal Implant (Nexplanon) Discontinuation Rate Study

NCT01397097 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

766

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: LNG-IUS (BAY 86-5028)
DRUG: 68 mg etonorgestrel implant for subdermal use (Nexplanon)

Sponsor

Bayer